These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 12843366)

  • 21. Covert operations of uropathogenic Escherichia coli within the urinary tract.
    Bower JM; Eto DS; Mulvey MA
    Traffic; 2005 Jan; 6(1):18-31. PubMed ID: 15569242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
    Mulvey MA; Schilling JD; Martinez JJ; Hultgren SJ
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8829-35. PubMed ID: 10922042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice.
    Iwahi T; Abe Y; Nakao M; Imada A; Tsuchiya K
    Infect Immun; 1983 Mar; 39(3):1307-15. PubMed ID: 6132876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A toll-like receptor that prevents infection by uropathogenic bacteria.
    Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
    Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
    Bishop BL; Duncan MJ; Song J; Li G; Zaas D; Abraham SN
    Nat Med; 2007 May; 13(5):625-30. PubMed ID: 17417648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Mulvey MA; Lopez-Boado YS; Wilson CL; Roth R; Parks WC; Heuser J; Hultgren SJ
    Science; 1998 Nov; 282(5393):1494-7. PubMed ID: 9822381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biogenesis of pili adhesins associated with urinary tract infectious Escherichia coli.
    Normark S; Hultgren S; Marklund BI; Strömberg N; Tennent J
    Antonie Van Leeuwenhoek; 1988; 54(5):405-9. PubMed ID: 2904797
    [No Abstract]   [Full Text] [Related]  

  • 30. New aspects of pathogenesis of lower urinary tract infections.
    Sobel JD
    Urology; 1985 Nov; 26(5 Suppl):11-6. PubMed ID: 3904135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Ratliff TL
    J Urol; 2005 Sep; 174(3):1150. PubMed ID: 16094085
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
    Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
    Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
    Martinez JJ; Mulvey MA; Schilling JD; Pinkner JS; Hultgren SJ
    EMBO J; 2000 Jun; 19(12):2803-12. PubMed ID: 10856226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escherichia coli infections.
    Levine MM
    N Engl J Med; 1985 Aug; 313(7):445-7. PubMed ID: 2862583
    [No Abstract]   [Full Text] [Related]  

  • 35. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.
    Restieri C; Garriss G; Locas MC; Dozois CM
    Appl Environ Microbiol; 2007 Mar; 73(5):1553-62. PubMed ID: 17220264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenetic aspects of uncomplicated urinary tract infection: recent advances.
    Fünfstück R; Smith JW; Tschäpe H; Stein G
    Clin Nephrol; 1997 Jan; 47(1):13-8. PubMed ID: 9021235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communal living by bacteria and the pathogenesis of urinary tract infections.
    Opal SM
    PLoS Med; 2007 Dec; 4(12):e349. PubMed ID: 18092887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escherichia coli virulence factors.
    Mainil J
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):2-12. PubMed ID: 23083938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunization of bacterial adherence to urothelium.
    Uehling DT; Mizutani K; Balish E
    Invest Urol; 1978 Sep; 16(2):145-7. PubMed ID: 361628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS; Jones TA; Sundsbak JL; Mulvey MA
    PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.